All Practice Exams

100+ Free CMPP Practice Questions

Pass your Certified Medical Publication Professional exam on the first try — instant access, no signup required.

✓ No registration✓ No credit card✓ No hidden fees✓ Start practicing immediately
~80% Pass Rate
100+ Questions
100% Free
1 / 10
Question 1
Score: 0/0

According to the ICMJE authorship criteria, how many criteria must an individual meet to qualify as an author on a manuscript?

A
B
C
D
to track
2026 Statistics

Key Facts: CMPP Exam

150

Questions

ISMPP

3 hours

Exam Duration

ISMPP

~80%

First-Attempt Pass Rate

ISMPP

$595

Member Exam Fee

ISMPP

3 years

Certification Validity

ISMPP Recertification

60-100 hrs

Typical Study Time

ISMPP Recommended

The CMPP is a 150-question, 3-hour, multiple-choice exam administered by ISMPP via Pearson VUE (testing centers worldwide and online via OnVUE). It is the only certification for medical publication professionals. Eligibility requires either a bachelor's degree plus 2 years (4,000 hours) of relevant experience or a high school diploma plus 5 years (10,000 hours). The exam fee is $595 for ISMPP members; non-members pay an additional $235 administrative fee. Candidates from developing countries pay $395. Test windows run periodically with application deadlines one month prior. The credential is valid for 3 years, after which holders must recertify through continuing education credits (≥8/year). ISMPP reports approximately 80% first-attempt pass rate. Core reference documents include GPP 2022, ICMJE Recommendations, the Declaration of Helsinki, the EQUATOR Network reporting guidelines, ClinicalTrials.gov/EudraCT requirements, the Sunshine Act, and the PhRMA/EFPIA Codes.

Sample CMPP Practice Questions

Try these sample questions to test your CMPP exam readiness. Each question includes a detailed explanation. Start the interactive quiz above for the full 100+ question experience with AI tutoring.

1According to the ICMJE authorship criteria, how many criteria must an individual meet to qualify as an author on a manuscript?
A.All 4 criteria
B.At least 2 of 4 criteria
C.Any 3 of 4 criteria
D.Only substantial contribution to study design
Explanation: The ICMJE Recommendations require that an author meet ALL four criteria: (1) substantial contributions to the conception or design of the work, or the acquisition, analysis, or interpretation of data; (2) drafting the work or revising it critically for important intellectual content; (3) final approval of the version to be published; and (4) agreement to be accountable for all aspects of the work. Meeting only some of the criteria is not sufficient for authorship.
2Under Good Publication Practice (GPP 2022), what is the appropriate way to recognize a professional medical writer who assisted with drafting a manuscript but did not meet ICMJE authorship criteria?
A.Named acknowledgment including their role, affiliation, and funding source
B.No recognition is necessary because they were paid
C.Listed as a non-author contributor only if the journal specifically asks
D.Include as a corresponding author but note their writing role
Explanation: GPP 2022 (the fourth iteration, often called GPP 2022 or the update to GPP3) and ICMJE both require that professional medical writers who do not meet authorship criteria be clearly acknowledged by name, with their role described (e.g., 'drafted the first version of the manuscript'), their affiliation stated, and the source of funding for their writing assistance disclosed. Hiding medical writer involvement is considered ghostwriting and is a form of research misconduct.
3Which reporting guideline should be used for a randomized controlled trial (RCT)?
A.CONSORT
B.PRISMA
C.STROBE
D.ARRIVE
Explanation: CONSORT (Consolidated Standards of Reporting Trials) is the reporting guideline for randomized controlled trials. The current version, CONSORT 2010, includes a 25-item checklist and a flow diagram. PRISMA is for systematic reviews and meta-analyses, STROBE is for observational studies, and ARRIVE is for preclinical animal research. The EQUATOR Network hosts all these guidelines.
4Per ICMJE, when must a clinical trial be registered for the results to be eligible for publication?
A.Prospectively, before enrollment of the first participant
B.Within 60 days of the first patient visit
C.Before database lock
D.Before the manuscript is submitted
Explanation: ICMJE requires prospective registration of clinical trials in a publicly accessible registry (e.g., ClinicalTrials.gov, EudraCT, ISRCTN) before enrollment of the first participant as a condition of consideration for publication. Retrospective registration is not acceptable to most ICMJE-compliant journals. This policy was adopted in 2005 to combat selective reporting and publication bias.
5A medical writer drafts a manuscript for an industry-sponsored trial without being named in the acknowledgments, and no writing assistance is disclosed. This is an example of:
A.Ghostwriting
B.Guest authorship
C.Honorary authorship
D.Duplicate publication
Explanation: Ghostwriting occurs when an individual (such as a professional medical writer) makes substantial contributions to a publication without being named as an author or acknowledged. It is considered a breach of publication ethics by ICMJE, WAME, GPP 2022, and the AMWA Code of Ethics. Guest authorship is the opposite problem: naming someone as an author who did not meet ICMJE criteria. Both practices compromise the integrity of the scientific literature.
6Which organization maintains the EQUATOR Network library of reporting guidelines?
A.A nonprofit network based at the University of Oxford
B.The International Committee of Medical Journal Editors (ICMJE)
C.The World Health Organization
D.The U.S. Food and Drug Administration
Explanation: The EQUATOR (Enhancing the QUAlity and Transparency Of health Research) Network is a nonprofit international initiative hosted at the UK EQUATOR Centre (based at the University of Oxford). It maintains a comprehensive online library of reporting guidelines including CONSORT, PRISMA, STROBE, CARE, SPIRIT, ARRIVE, STARD, and many others. It is not operated by ICMJE, WHO, or FDA.
7Under GPP 2022, who has ultimate responsibility for ensuring the publication is accurate, transparent, and compliant with guidelines?
A.All authors collectively, with the sponsor/company ensuring processes support compliance
B.The corresponding author alone
C.The medical writer engaged for the project
D.The journal editor and peer reviewers
Explanation: GPP 2022 specifies that authors have collective responsibility for the accuracy, completeness, and transparency of the publication, while sponsors (e.g., pharmaceutical companies) are responsible for ensuring that processes, resources, and training support compliance with publication guidelines. Medical writers assist but cannot replace author responsibility, and journal editors/reviewers assess quality but are not primarily responsible for content accuracy.
8A publication plan is typically developed at which stage of a compound's lifecycle?
A.Before Phase 3 pivotal trials, ideally during Phase 2 or earlier
B.Only after regulatory approval
C.At the time of manuscript submission
D.After the first commercial launch
Explanation: Effective publication planning begins early in the compound's lifecycle, ideally during or before Phase 2 development and well before the pivotal Phase 3 trials are complete. Early planning allows for coordination of scientific communication, congress abstracts, primary manuscripts, secondary analyses, and post-marketing publications in a transparent, strategic manner. Waiting until regulatory approval or manuscript submission is too late.
9According to ClinicalTrials.gov reporting requirements under the Final Rule (42 CFR Part 11), when must summary results typically be posted after the primary completion date?
A.Within 12 months
B.Within 6 months
C.Within 24 months
D.At the time of publication only
Explanation: The FDAAA 801 Final Rule (42 CFR Part 11) requires that summary results information for applicable clinical trials be submitted to ClinicalTrials.gov no later than 12 months after the primary completion date, regardless of whether the results have been published. Extensions may be granted under specific circumstances. Failure to comply can result in civil monetary penalties and withholding of NIH grant funds.
10Which reporting guideline is designed for systematic reviews and meta-analyses?
A.PRISMA
B.CONSORT
C.STROBE
D.SPIRIT
Explanation: PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses) is the standard reporting guideline for systematic reviews and meta-analyses. PRISMA 2020 replaced the original 2009 statement and includes a 27-item checklist and flow diagram. CONSORT is for RCTs, STROBE is for observational studies, and SPIRIT is for clinical trial protocols.

About the CMPP Exam

The ISMPP CMPP (Certified Medical Publication Professional) credential is the only certification designed specifically for professionals working in medical publications — medical writers, publication planners, editors, and agency or pharma publication staff. The exam tests knowledge of publication planning, development, ethics, disclosure/transparency, and post-publication metrics, grounded in GPP 2022, ICMJE Recommendations, CONSORT/PRISMA/STROBE/SPIRIT/ARRIVE reporting guidelines, and global regulatory frameworks.

Questions

150 scored questions

Time Limit

3 hours

Passing Score

Scaled passing score (criterion-referenced, pass/fail)

Exam Fee

$595 (members) / $595 + $235 admin fee (non-members) (ISMPP)

CMPP Exam Content Outline

~35%

Developing a Publication Plan

Publication planning strategy, lifecycle management, audience identification, journal and congress selection, scientific platform/messages, authorship determination per ICMJE, publication steering committees, publication agreements, timelines, and gap analyses

~35%

Implementing a Publication Plan

Manuscript development, reporting guidelines (CONSORT, PRISMA, STROBE, SPIRIT, ARRIVE, RECORD), peer review, response to reviewers, journal selection and resubmission, preprints, congress abstracts, plain language summaries, enhanced content, and embargo/press-release coordination

~30%

Fostering Ethical and Compliant Behavior

GPP 2022, ICMJE Recommendations, Declaration of Helsinki, authorship and ghostwriting/guest authorship, conflict of interest disclosure, clinical trial registration and results disclosure (FDAAA 801, EU CTR, ClinicalTrials.gov, CTIS), data sharing (FAIR, IPD), Sunshine Act / Open Payments, PhRMA and EFPIA Codes, FDA and EMA promotional/non-promotional rules, HIPAA, GDPR, copyright, and retractions

How to Pass the CMPP Exam

What You Need to Know

  • Passing score: Scaled passing score (criterion-referenced, pass/fail)
  • Exam length: 150 questions
  • Time limit: 3 hours
  • Exam fee: $595 (members) / $595 + $235 admin fee (non-members)

Keys to Passing

  • Complete 500+ practice questions
  • Score 80%+ consistently before scheduling
  • Focus on highest-weighted sections
  • Use our AI tutor for tough concepts

CMPP Study Tips from Top Performers

1Read GPP 2022 cover to cover — it is the foundational document for industry publication ethics and heavily tested on the CMPP exam
2Memorize the 4 ICMJE authorship criteria (contribution, drafting/revising, final approval, accountability) — you must meet ALL four to qualify as an author
3Learn the EQUATOR Network reporting guidelines by study type: CONSORT (RCTs), PRISMA (systematic reviews), STROBE (observational), SPIRIT (protocols), ARRIVE (animal), STARD (diagnostic), CARE (case reports)
4Study clinical trial registration rules: FDAAA 801 (US), EU CTR (EU), ICMJE prospective registration policy, and ClinicalTrials.gov 12-month results posting requirement
5Understand the distinction between promotional and non-promotional communications under FDA, EMA, PhRMA, and EFPIA frameworks — this is a common exam topic
6Complete at least 2-3 full-length timed practice exams before your test window to build pacing and identify weak areas
7Use ISMPP U free webinars and the CMPP Supplemental Reference List — the exam draws directly from these resources

Frequently Asked Questions

What is the ISMPP CMPP exam format?

The CMPP exam consists of 150 psychometrically validated multiple-choice questions delivered by Pearson VUE, either at a Pearson VUE testing center or online via OnVUE proctored delivery. You have 3 hours to complete the exam. It is a pass/fail credential based on a criterion-referenced scaled score. Approximately 80% of candidates pass on first attempt.

Who is eligible to take the CMPP exam?

ISMPP requires either a bachelor's degree plus 2 years (4,000 hours) of relevant medical publication experience, OR a high school diploma plus 5 years (10,000 hours) of relevant experience. Candidates must also hold ISMPP membership (or pay a $235 non-member administrative fee that includes one year of membership). Relevant experience includes medical writing, publication planning, editorial work, and publication management at pharmaceutical companies, agencies, or CROs.

How much does the CMPP exam cost in 2026?

The CMPP exam fee is $595 for ISMPP members. Non-members pay $595 plus a $235 administrative fee (which includes one year of ISMPP membership), for a total of $830. Candidates from developing countries pay a reduced fee of $395. Retakes within the next testing window cost $250. Fees are set by ISMPP and are subject to change — always verify on the official ISMPP exam details page.

What content does the CMPP exam cover?

The CMPP examination blueprint covers three major knowledge domains: (1) Developing a publication plan — strategy, authorship, journal/congress selection, steering committees; (2) Implementing a publication plan — manuscript development, reporting guidelines, peer review, and alternative formats; and (3) Fostering ethical and compliant behavior — GPP 2022, ICMJE, trial registration, disclosure, Sunshine Act, PhRMA/EFPIA Codes, and FDA/EMA promotional regulations. Key reference documents include GPP 2022, ICMJE Recommendations, the Declaration of Helsinki, EQUATOR Network guidelines, and major regulatory frameworks.

How long should I study for the CMPP exam?

ISMPP recommends 60-100 hours of study over 2-4 months for candidates with solid medical publication experience. New entrants or those with gaps in specific areas (e.g., regulatory or ethics) may need more. Most candidates use the official Candidate Handbook, the CMPP Supplemental Reference List, ISMPP U modules, and practice questions. Reading the primary source documents — GPP 2022, ICMJE Recommendations, CONSORT 2010, PRISMA 2020 — is essential.

What are the CMPP recertification requirements?

The CMPP credential is valid for 3 years. To recertify, CMPPs must earn at least 24 continuing education (CE) credits over the 3-year cycle (typically at least 8 per year, with no more than 12 allowed in the final year). CE credits can be earned via free ISMPP U monthly webinars, ISMPP Annual Meeting sessions, pre-approved external activities, and other approved continuing education. Recertification fees apply. Details are in the ISMPP CMPP Recertification Handbook.

Is CMPP recognized worldwide?

Yes. The CMPP is the only internationally recognized certification for medical publication professionals and is accepted across the pharmaceutical industry, medical communications agencies, and contract research organizations globally. Thousands of professionals from over 40 countries have earned the credential since its launch in 2009. It is particularly valued in the US, UK, EU, Australia, and Japan markets.

What is GPP 2022 and why is it important for the CMPP exam?

GPP 2022 (Good Publication Practice, 2022 update) is the leading international consensus guideline for company-sponsored medical publications. It addresses authorship (aligned with ICMJE's four criteria), medical writer acknowledgment, ghostwriting, sponsor review processes, publication agreements, and transparency. GPP 2022 is heavily represented on the CMPP exam and candidates must be familiar with its full text, available free from the MAP Newsletter/ISMPP resources.